Clinical Trials Browser

Genetic Risk Score, Atrial Fibrillation, Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Type 2, Prostatic Neoplasms, Colorectal Neoplasms

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Phase 3 Withdrawn

Genitourinary

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive

NCT01230905 2017-04-24

AST

Phase 4 Completed

181 enrolled

Genitourinary

Coronary Artery Disease, Prostatic Neoplasms

NCT01446224 2015-03-27

Cardiovascular and Torsades de Pointes Monitoring for Pazopanib

Completed

1 enrolled

Genitourinary

Carcinoma, Renal Cell, Coronary Artery Disease

NCT00325611 2006-05-15

Multidisciplinary Inpatient Palliative Care Intervention

Phase NA Completed

550 enrolled

Genitourinary

Acquired Immunodeficiency Syndrome, Coronary Artery Disease, Dementia, Diabetes Mellitus, Failure to Thrive, Heart Failure, Kidney Failure, Chronic, Neoplasms, Pneumonia, Respiratory Insufficiency, Liver Failure, Stroke, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency

Clinical Trials

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

FHAMe

GenoVA

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

AST

Cardiovascular and Torsades de Pointes Monitoring for Pazopanib

Multidisciplinary Inpatient Palliative Care Intervention